Nafarelin
Synarel (nafarelin) is a protein pharmaceutical. Nafarelin was first approved as Synarel on 1990-02-13. It is used to treat endometriosis and precocious puberty in the USA. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
| Trade Name | Synarel |
|---|---|
| Common Name | Nafarelin |
| Indication | endometriosis, precocious puberty |
| Drug Class | Prehormones or hormone-release stimulating peptides |
